HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabapentin for Kleine-Levin syndrome.

Abstract
We describe a 17-year-old girl with Kleine-Levin syndrome (KLS), in which gabapentin was effective for the prevention of attacks. (99)mTc-ECD SPECT revealed hyperperfusion of the thalamus and nucleus accumbens presenting in the symptomatic period, suggesting epilepsy-like neuronal discharge from these structures. Treatment for KLS has not been established, although lithium has been used in limited cases with insignificant efficacy. Here, we report a case of recurrent hypersomnia in which gabapentin was effective for the prevention of attacks. We speculate that the recurrent hypersomnia and behaviour disturbance are related to epilepsy-like neuronal discharge from the thalamus due to dysfunction in GABAnergic receptors.
AuthorsKaori Itokawa, Miki Fukui, Mikiko Ninomiya, Toshimasa Yamamoto, Etsuko Imabayashi, Naotoshi Tamura, Hiroshi Matsuda, Nobuo Araki
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 48 Issue 13 Pg. 1183-5 ( 2009) ISSN: 1349-7235 [Electronic] Japan
PMID19571456 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amines
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • Receptors, GABA-A
  • gamma-Aminobutyric Acid
  • Gabapentin
Topics
  • Adolescent
  • Amines (therapeutic use)
  • Anticonvulsants (therapeutic use)
  • Cyclohexanecarboxylic Acids (therapeutic use)
  • Electroencephalography
  • Female
  • Gabapentin
  • Humans
  • Kleine-Levin Syndrome (diagnosis, drug therapy, physiopathology)
  • Magnetic Resonance Imaging
  • Receptors, GABA-A (physiology)
  • Tomography, Emission-Computed, Single-Photon
  • gamma-Aminobutyric Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: